dc.contributor.author |
Nanna U. |
|
dc.contributor.author |
Naowaboot J. |
|
dc.contributor.author |
Chularojmontri L. |
|
dc.contributor.author |
Tingpej P. |
|
dc.contributor.author |
Wattanapitayakul S. |
|
dc.date.accessioned |
2021-04-05T03:03:51Z |
|
dc.date.available |
2021-04-05T03:03:51Z |
|
dc.date.issued |
2019 |
|
dc.identifier.issn |
22211691 |
|
dc.identifier.other |
2-s2.0-85061075624 |
|
dc.identifier.uri |
https://ir.swu.ac.th/jspui/handle/123456789/12503 |
|
dc.identifier.uri |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061075624&doi=10.4103%2f2221-1691.250859&partnerID=40&md5=e94451058ffd29e9686f6d8b93de9b6f |
|
dc.description.abstract |
Objective: To examine the effect of Brassica oleracea extract (BO) on impaired glucose and lipid homeostasis in high-fat diet (HFD)-induced obese mice. Methods: Obesity of ICR mice was induced by feeding a HFD (45 kcal% lard fat) for 16 weeks. During the last 8 weeks of study period, obese mice were additionally administered with BO (100 and 200 mg/kg/day). The metabolic parameters were determined. The gene expressions of hepatic lipogenesis were also studied. Results: After 8 weeks of treatment, BO (100 and 200 mg/kg) significantly reduced hyperglycemia and improved insulin sensitivity (P < 0.05). The serum lipid (total cholesterol, triglyceride, and non-esterified fatty acid) and hepatic triglyceride and non-esterified fatty acid were decreased (P < 0.05). The levels of insulin and leptin in serum were also decreased (P < 0.05). Moreover, the expressions of hepatic lipogenic genes including sterol regulatory element-binding protein 1c, fatty acid synthase, and acetyl-CoA carboxylase were decreased by BO treatment (P < 0.05). Conclusions: These results suggest that BO is a new therapeutic agent for improving the homeostasis of glucose and lipid in HFD-induced obese mice probably by suppression of lipogenic genes in liver tissue. © 2019 Asian Pacific Journal of Tropical Biomedicine Produced by Wolters Kluwer-Medknow. |
|
dc.subject |
acetyl coenzyme A carboxylase |
|
dc.subject |
antidiabetic agent |
|
dc.subject |
Brassica oleracea extract |
|
dc.subject |
cholesterol |
|
dc.subject |
fatty acid |
|
dc.subject |
fatty acid synthase |
|
dc.subject |
glucose |
|
dc.subject |
insulin |
|
dc.subject |
leptin |
|
dc.subject |
plant extract |
|
dc.subject |
sterol regulatory element binding protein 1c |
|
dc.subject |
triacylglycerol |
|
dc.subject |
unclassified drug |
|
dc.subject |
animal experiment |
|
dc.subject |
animal model |
|
dc.subject |
animal tissue |
|
dc.subject |
Article |
|
dc.subject |
Brassica oleracea |
|
dc.subject |
cholesterol blood level |
|
dc.subject |
controlled study |
|
dc.subject |
diet induced obesity |
|
dc.subject |
fatty acid blood level |
|
dc.subject |
gene expression |
|
dc.subject |
glucose homeostasis |
|
dc.subject |
hormone blood level |
|
dc.subject |
impaired glucose tolerance |
|
dc.subject |
insulin blood level |
|
dc.subject |
insulin sensitivity |
|
dc.subject |
lipid blood level |
|
dc.subject |
lipid diet |
|
dc.subject |
lipid homeostasis |
|
dc.subject |
lipogenesis |
|
dc.subject |
male |
|
dc.subject |
mouse |
|
dc.subject |
nonhuman |
|
dc.subject |
priority journal |
|
dc.subject |
treatment duration |
|
dc.subject |
triacylglycerol blood level |
|
dc.title |
Effects of Brassica oleracea extract on impaired glucose and lipid homeostasis in high-fat diet-induced obese mice |
|
dc.type |
Article |
|
dc.rights.holder |
Scopus |
|
dc.identifier.bibliograpycitation |
Asian Pacific Journal of Tropical Biomedicine. Vol 9, No.2 (2019), p.80-84 |
|
dc.identifier.doi |
10.4103/2221-1691.250859 |
|